USANA Health Sciences Statistics
Total Valuation
USNA has a market cap or net worth of $360.28 million. The enterprise value is $234.04 million.
Important Dates
The next confirmed earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
USNA has 18.46 million shares outstanding. The number of shares has decreased by -3.07% in one year.
| Current Share Class | 18.46M |
| Shares Outstanding | 18.46M |
| Shares Change (YoY) | -3.07% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 41.11% |
| Owned by Institutions (%) | 50.77% |
| Float | 9.69M |
Valuation Ratios
The trailing PE ratio is 33.66 and the forward PE ratio is 10.01. USNA's PEG ratio is 0.83.
| PE Ratio | 33.66 |
| Forward PE | 10.01 |
| PS Ratio | 0.39 |
| Forward PS | 0.37 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | 42.28 |
| P/OCF Ratio | 16.13 |
| PEG Ratio | 0.83 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 2.81, with an EV/FCF ratio of 27.45.
| EV / Earnings | 21.75 |
| EV / Sales | 0.25 |
| EV / EBITDA | 2.81 |
| EV / EBIT | 4.60 |
| EV / FCF | 27.45 |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.24 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | 3.75 |
| Interest Coverage | 60.41 |
Financial Efficiency
Return on equity (ROE) is 1.96% and return on invested capital (ROIC) is 3.03%.
| Return on Equity (ROE) | 1.96% |
| Return on Assets (ROA) | 4.26% |
| Return on Invested Capital (ROIC) | 3.03% |
| Return on Capital Employed (ROCE) | 8.28% |
| Weighted Average Cost of Capital (WACC) | 7.52% |
| Revenue Per Employee | $589,336 |
| Profits Per Employee | $6,854 |
| Employee Count | 1,570 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 2.33 |
Taxes
In the past 12 months, USNA has paid $30.05 million in taxes.
| Income Tax | 30.05M |
| Effective Tax Rate | 72.36% |
Stock Price Statistics
The stock price has decreased by -28.18% in the last 52 weeks. The beta is 0.70, so USNA's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -28.18% |
| 50-Day Moving Average | 18.69 |
| 200-Day Moving Average | 23.01 |
| Relative Strength Index (RSI) | 57.51 |
| Average Volume (20 Days) | 105,688 |
Short Selling Information
The latest short interest is 477,879, so 2.59% of the outstanding shares have been sold short.
| Short Interest | 477,879 |
| Short Previous Month | 453,571 |
| Short % of Shares Out | 2.59% |
| Short % of Float | 4.93% |
| Short Ratio (days to cover) | 3.86 |
Income Statement
In the last 12 months, USNA had revenue of $925.26 million and earned $10.76 million in profits. Earnings per share was $0.58.
| Revenue | 925.26M |
| Gross Profit | 724.41M |
| Operating Income | 50.86M |
| Pretax Income | 41.53M |
| Net Income | 10.76M |
| EBITDA | 83.42M |
| EBIT | 50.86M |
| Earnings Per Share (EPS) | $0.58 |
Full Income StatementBalance Sheet
The company has $158.38 million in cash and $31.96 million in debt, giving a net cash position of $126.42 million or $6.85 per share.
| Cash & Cash Equivalents | 158.38M |
| Total Debt | 31.96M |
| Net Cash | 126.42M |
| Net Cash Per Share | $6.85 |
| Equity (Book Value) | 586.27M |
| Book Value Per Share | 29.16 |
| Working Capital | 159.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $22.35 million and capital expenditures -$13.82 million, giving a free cash flow of $8.53 million.
| Operating Cash Flow | 22.35M |
| Capital Expenditures | -13.82M |
| Depreciation & Amortization | 32.56M |
| Net Borrowing | -9.00M |
| Free Cash Flow | 8.53M |
| FCF Per Share | $0.46 |
Full Cash Flow StatementMargins
Gross margin is 78.29%, with operating and profit margins of 5.50% and 1.16%.
| Gross Margin | 78.29% |
| Operating Margin | 5.50% |
| Pretax Margin | 4.49% |
| Profit Margin | 1.16% |
| EBITDA Margin | 9.02% |
| EBIT Margin | 5.50% |
| FCF Margin | 0.92% |